Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rathan M Subramaniam

Showing results (181-190 of 255) with videos related to

Pageof 26
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 12, 2012
18F-FDG metabolic tumor volume and total glycolytic activity of oral cavity and oropharyngeal squamous cell cancer: adding value to clinical stagingElizabeth H Dibble, Ana C Lara Alvarez, Minh-Tam Truong, et al.
Mayo Clinic Proceedings|August 5, 2008
Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: value of positron emission tomography in diagnosisRajesh R Patel, Rathan M Subramaniam, Jaywant N Mandrekar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 5, 2016
Clinical Indications and Impact on Management: Fourth and Subsequent Posttherapy Follow-up <sup>18</sup>F-FDG PET/CT Scans in Oncology PatientsMehdi Taghipour, Charles Marcus, Sara Sheikhbahaei, et al.
International Review of Cell and Molecular Biology|February 15, 2024
Genetic and epigenetic features of neuroendocrine prostate cancer and their emerging applicationsXintong Zhang, Edward Barnett, Jim Smith, et al.
Head & Neck|February 14, 2024
Quality of life following surgery for head and neck cancer: Evidence from ACRIN 6685Christopher S Hollenbeak, Fenghai Duan, Rathan M Subramaniam, et al.
Physics in Medicine and Biology|December 8, 2015
A novel metric for quantification of homogeneous and heterogeneous tumors in PET for enhanced clinical outcome predictionArman Rahmim, C Ross Schmidtlein, Andrew Jackson, et al.
The Oncologist|July 13, 2016
Impact on Patient Management of [18F]-Fluorodeoxyglucose-Positron Emission Tomography (PET) Used for Cancer Diagnosis: Analysis of Data From the National Oncologic PET RegistryRathan M Subramaniam, Anthony F Shields, Archana Sachedina, et al.
Clinical Nuclear Medicine|May 31, 2014
Liver standardized uptake value corrected for lean body mass at FDG PET/CT: effect of FDG uptake timeAlin Chirindel, Krishna C Alluri, Abdel K Tahari, et al.
AJR. American Journal of Roentgenology|June 28, 2018
PET/CT of DementiaKatherine Zukotynski, Phillip H Kuo, David Mikulis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 9, 2013
Addition of 18F-FDG PET/CT to clinical assessment predicts overall survival in HNSCC: a retrospective analysis with follow-up for 12 yearsVasavi Paidpally, Abdel K Tahari, Stella Lam, et al.
Pageof 26

Showing results (181-190 of 255) with videos related to

Sort By:
Pageof 26
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 12, 2012
18F-FDG metabolic tumor volume and total glycolytic activity of oral cavity and oropharyngeal squamous cell cancer: adding value to clinical stagingElizabeth H Dibble, Ana C Lara Alvarez, Minh-Tam Truong, et al.
Mayo Clinic Proceedings|August 5, 2008
Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: value of positron emission tomography in diagnosisRajesh R Patel, Rathan M Subramaniam, Jaywant N Mandrekar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 5, 2016
Clinical Indications and Impact on Management: Fourth and Subsequent Posttherapy Follow-up <sup>18</sup>F-FDG PET/CT Scans in Oncology PatientsMehdi Taghipour, Charles Marcus, Sara Sheikhbahaei, et al.
International Review of Cell and Molecular Biology|February 15, 2024
Genetic and epigenetic features of neuroendocrine prostate cancer and their emerging applicationsXintong Zhang, Edward Barnett, Jim Smith, et al.
Head & Neck|February 14, 2024
Quality of life following surgery for head and neck cancer: Evidence from ACRIN 6685Christopher S Hollenbeak, Fenghai Duan, Rathan M Subramaniam, et al.
Physics in Medicine and Biology|December 8, 2015
A novel metric for quantification of homogeneous and heterogeneous tumors in PET for enhanced clinical outcome predictionArman Rahmim, C Ross Schmidtlein, Andrew Jackson, et al.
The Oncologist|July 13, 2016
Impact on Patient Management of [18F]-Fluorodeoxyglucose-Positron Emission Tomography (PET) Used for Cancer Diagnosis: Analysis of Data From the National Oncologic PET RegistryRathan M Subramaniam, Anthony F Shields, Archana Sachedina, et al.
Clinical Nuclear Medicine|May 31, 2014
Liver standardized uptake value corrected for lean body mass at FDG PET/CT: effect of FDG uptake timeAlin Chirindel, Krishna C Alluri, Abdel K Tahari, et al.
AJR. American Journal of Roentgenology|June 28, 2018
PET/CT of DementiaKatherine Zukotynski, Phillip H Kuo, David Mikulis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 9, 2013
Addition of 18F-FDG PET/CT to clinical assessment predicts overall survival in HNSCC: a retrospective analysis with follow-up for 12 yearsVasavi Paidpally, Abdel K Tahari, Stella Lam, et al.
Pageof 26